Adela

OverviewSuggest Edit

Adela (formerly known as DNAMx) is a company that specializes in the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. Its genome-wide methylation enrichment technology offers the potential to detect many diseases with a single assay.

TypePrivate
Founded2020
HQToronto, CA
Websiteadelabio.com

Locations

Adela is headquartered in
Toronto, Canada

Location Map

Latest Updates

Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Adela

Scott Bratman

Scott Bratman

Chief Executive Officer
Anne-Renee Hartman

Anne-Renee Hartman

Chief Medical Officer
Daniel de Carvalho

Daniel de Carvalho

Chief Scientific Officer
Show more

Adela Office Locations

Adela has offices in Toronto, San Francisco and New Haven
San Francisco, CA, US
San Francisco
Show all (3)

Adela Financials and Metrics

Summary Metrics

Founding Date

2020

Adela total Funding

$60 m

Adela latest funding size

$60 m

Time since last funding

a year ago

Adela investors

Adela's latest funding round in June 2021 was reported to be $60 m. In total, Adela has raised $60 m
Show all financial metrics

Adela Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Adela Online and Social Media Presence

Embed Graph

Adela Frequently Asked Questions

  • When was Adela founded?

    Adela was founded in 2020.

  • Who are Adela key executives?

    Adela's key executives are Scott Bratman, Anne-Renee Hartman and Daniel de Carvalho.

  • Who are Adela competitors?

    Competitors of Adela include MyC, Thymia and Valeo.

  • Where are Adela offices?

    Adela has offices in Toronto, San Francisco and New Haven.

  • How many offices does Adela have?

    Adela has 3 offices.